Cobas® Ebv
Payments companies reported to CMS as associated with Cobas® Ebv. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Cobas® Ebv, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Cobas® Ebv
These are the largest totals companies reported as associated with Cobas® Ebv. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| David Gaston | Nashville, TN | Medical Microbiology | $145.28 |
| Niaz Banaei | Stanford, CA | Anatomic Pathology & Clinical Pathology | $116.54 |
| Benjamin Pinsky | Stanford, CA | Anatomic Pathology & Clinical Pathology | $91.43 |
Prescribed Cobas® Ebv?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.